{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:19:50Z","timestamp":1785550790924,"version":"3.56.0"},"reference-count":38,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CLEP"],"DOI":"10.2147\/clep.s413587","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T01:55:13Z","timestamp":1695002113000},"page":"987-999","source":"Crossref","is-referenced-by-count":5,"title":["Use of Linked Nordic Registries for Population Studies in Hematologic Cancers: The Case of Multiple Myeloma"],"prefix":"10.2147","volume":"Volume 15","author":[{"given":"Niels","family":"Abildgaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonatan","family":"Freilich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pekka","family":"Anttila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawal","family":"Bent-Ennakhil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariann","family":"Lassenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigurd","family":"\u00d8rstavik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iiro","family":"Toppila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Waage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingemar","family":"Turesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7715-4548","authenticated-orcid":true,"given":"Markus","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1126\/science.287.5462.2398","volume":"287","author":"Frank","year":"2000","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s10654-013-9873-0","volume":"29","author":"Thygesen","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3332\/ecancer.2016.641","volume":"10","author":"Forsea","year":"2016","journal-title":"Ecancermedicalscience"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ejca.2018.09.001","volume":"104","author":"Zanetti","year":"2018","journal-title":"Eur J Cancer"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1742-7843.2009.00494.x","volume":"106","author":"Furu","year":"2010","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/1403494811399956","volume":"39","author":"Thygesen","year":"2011","journal-title":"Scand J Public Health"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1177\/1403494819858046","volume":"47","author":"Van Der Wel","year":"2019","journal-title":"Scand J Public Health"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/1403494817702336","volume":"45","author":"Maret-Ouda","year":"2017","journal-title":"Scand J Public Health"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2147\/CLEP.S314959","volume":"13","author":"Laugesen","year":"2021","journal-title":"Clin Epidemiol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1080\/0284186x.2020.1820573","volume":"59","author":"Nilbert","year":"2020","journal-title":"Acta Oncol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1080\/0284186x.2017.1407039","volume":"57","author":"Pukkala","year":"2018","journal-title":"Acta Oncol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/pds.3457","volume":"22","author":"Wettermark","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.ejca.2014.02.008","volume":"51","author":"Gavin","year":"2015","journal-title":"Eur J Cancer"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3109\/0284186x.2015.1127416","volume":"55","author":"Leinonen","year":"2016","journal-title":"Acta Oncol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.3390\/ijms19113613","volume":"19","author":"Castella","year":"2018","journal-title":"Int J Mol Sci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/s1470-2045(14)70442-5","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1001\/jamaoncol.2018.2128","volume":"4","author":"Cowan","year":"2018","journal-title":"JAMA Oncol"},{"key":"ref18","unstructured":"Danish Health Data Authority. National patient register. Available from: https:\/\/sundhedsdatastyrelsen.dk\/da\/registre-og-services\/om-de-nationale-sundhedsregistre\/sygdomme-laegemidler-og-behandlinger\/landspatientregisteret. Accessed March 6, 2023."},{"key":"ref19","unstructured":"Finnish Institute for Health and Welfare (THL). Finnish national care register for healthcare institutions (HILMO). Available from: https:\/\/thl.fi\/en\/web\/thlfi-en\/statistics-and-data\/data-and-services\/register-descriptions\/care-register-for-health-care. Accessed March 6, 2023."},{"key":"ref20","unstructured":"Finnish Institute for Health and Welfare (THL). Primary health care outpatient care notification (AvoHILMO). Available from: https:\/\/thl.fi\/fi\/tilastot-ja-data\/ohjeet-tietojen-toimittamiseen\/perusterveydenhuollon-avohoidon-hoitoilmoitus-avohilmo. Accessed March 6, 2023."},{"key":"ref21","unstructured":"The National Board of Health and Welfare, Sweden. National patient register. Available from: https:\/\/www.socialstyrelsen.se\/en\/statistics-and-data\/registers\/national-patient-register\/. Accessed March 6, 2023."},{"key":"ref22","unstructured":"Danish Health Data Authority. Medicines statistics register. Available from: https:\/\/sundhedsdatastyrelsen.dk\/da\/registre-og-services\/om-de-nationale-sundhedsregistre\/sygdomme-laegemidler-og-behandlinger\/laegemiddelstatistikregisteret. Accessed March 7, 2023."},{"key":"ref23","unstructured":"Kela. Deliveries of medicines reimbursed by health insurance. Available from: https:\/\/www.stat.fi\/tilasto\/resep. Accessed March 7, 2023."},{"key":"ref24","unstructured":"The National Board of Health and Welfare, Sweden. National prescribed drug register. Available from: https:\/\/www.socialstyrelsen.se\/en\/statistics-and-data\/registers\/national-prescribed-drug-register\/. Accessed March 7, 2023."},{"key":"ref25","unstructured":"Danish Health Data Authority. Cancer registry. Available from: https:\/\/sundhedsdatastyrelsen.dk\/da\/registre-og-services\/om-de-nationale-sundhedsregistre\/sygdomme-laegemidler-og-behandlinger\/cancerregisteret. Accessed March 7, 2023."},{"key":"ref26","unstructured":"Cancer Society of Finland. Finnish cancer registry. Available from: https:\/\/syoparekisteri.fi\/. Accessed March 7, 2023."},{"key":"ref27","unstructured":"The National Board of Health and Welfare, Sweden. National cancer register. Available from: https:\/\/www.socialstyrelsen.se\/en\/statistics-and-data\/registers\/national-cancer-register\/. Accessed March 7, 2023."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejca.2017.02.017","volume":"77","author":"Leinonen","year":"2017","journal-title":"Eur J Cancer"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1177\/1403494812456637","volume":"40","author":"Sund","year":"2012","journal-title":"Scand J Public Health"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2147\/clep.S90589","volume":"7","author":"Ludvigsson","year":"2015","journal-title":"Clin Epidemiol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2147\/clep.S99463","volume":"8","author":"Gimsing","year":"2016","journal-title":"Clin Epidemiol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3324\/haematol.2017.178103","volume":"103","author":"Blimark","year":"2018","journal-title":"Haematologica"},{"key":"ref33","unstructured":"Regional Cancer Centres Samverkan. Individuell patient\u00f6versikt (IP\u00d6) i cancerv\u00e5rden [Individual patient overview (IP\u00d6) in cancer care]. Swedish. Available from: https:\/\/cancercentrum.se\/samverkan\/vara-uppdrag\/kunskapsstyrning\/patientoversikter\/. Accessed June 28, 2023."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e009584","DOI":"10.1136\/bmjopen-2015-009584","volume":"6","author":"V\u00e9lez","year":"2016","journal-title":"BMJ Open"},{"key":"ref35","first-page":"98","volume":"2018","author":"Pitk\u00e4niemi","year":"2018","journal-title":"Cancer Soc Finland Pub"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/ejh.13615","volume":"107","author":"Hannig","year":"2021","journal-title":"Eur J Haematol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/ejh.13623","volume":"107","author":"Borgsten","year":"2021","journal-title":"Eur J Haematol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/bjh.16674","volume":"191","author":"Langseth","year":"2020","journal-title":"Br J Haematol"}],"container-title":["Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=92848","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=92848","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T01:55:20Z","timestamp":1695002120000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/use-of-linked-nordic-registries-for-population-studies-in-hematologic--peer-reviewed-fulltext-article-CLEP"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":38,"URL":"https:\/\/doi.org\/10.2147\/clep.s413587","relation":{},"ISSN":["1179-1349"],"issn-type":[{"value":"1179-1349","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}